Why Cardiology Is Pushing for Transparent Medicare Payment Formulas

For Australian patients and clinicians watching the slow-motion American cardiology crisis, the headlines can feel distant. Washington, lobbying groups, fee schedules. Yet the underlying question travels surprisingly well: how should a society price the work of saving a heart? When a payment formula is opaque, the people relying on it lose the ability to hold the system accountable for outcomes that matter at the kitchen table in Brisbane or the cardiac ward in Melbourne.

The Campaign for Patient Access, launched by the American College of Cardiology, has spent years pushing back against Medicare physician fee schedule cuts that the cardiology community argues were assembled using flawed methodology. Transparency sits at the centre of that fight, because without clear numbers, neither patients nor practices can evaluate whether a cut is justified or politically convenient. The stakes extend beyond the United States, since payment-system design in major English-speaking economies tends to influence one another, and Australian specialists often participate in the same global cardiology forums where these formulas are dissected.

The Heart of the Payment Dispute

At its core, the campaign argues that cardiology reimbursements in the US Medicare system have been trimmed year after year through budget-neutrality adjustments, misvalued codes, and updates to practice expense inputs that practitioners rarely see explained. A Sydney electrophysiologist who trained in Boston still remembers how cuts announced as technical refinements translated into real payroll decisions back in his US practice. The episode is a reminder that policy language travels further than the people who wrote it.

The campaign's central demand is straightforward: publish the underlying calculations in a form that independent analysts can replicate. When formulas used to value catheter ablation, pacemaker implantation, or echocardiography are hidden behind agency discretion, errors persist. Specialists who flag anomalies often find the regulator defending a number rather than walking through the arithmetic. Patients have no ready way to know whether access to a nearby cardiology service is shrinking because of science, statistics, or something else entirely.

Australian readers will recognise the parallel with the Medicare Benefits Schedule Review at home. Every few years, the MBS is revised under the gaze of clinician committees and the Department of Health, with varying levels of transparency depending on the item. The lesson from the American experience is that even a robust review process can drift if the rationale for each change is not preserved in public documentation. Open methodology is what turns a fee schedule into a shared reference rather than a sealed verdict.

How the Numbers Are Built and Why Visibility Matters

Most readers do not realise how granular the building blocks of a physician payment actually are. They involve work-RVU values, which capture the relative effort, skill, and time assigned to a service, alongside practice expense inputs such as rent, equipment, and supplies, professional liability factors, and geographic adjusters. Multiply the work and practice components, add the liability portion, adjust for locality, and the result is a figure scaled by a conversion factor set annually. Each step is a flashpoint. Strip out a fraction of a practice expense dollar here, adjust a malpractice coefficient there, and a specialty absorbs significant losses without a single headline to mark the moment.

Until recently, clinicians were expected to absorb these shifts as routine housekeeping. The campaign rejects that framing, pointing out that routine adjustments to cardiology have produced roughly thirteen years of consecutive decline in real terms. Independent reviews of those trends, such as those documented in MedPAC cardiology findings, often note the cumulative impact but rarely translate it into plain-language guidance for the public. Patients deserve to see those conclusions alongside the underlying work, rather than as footnotes in a policy memo.

Comparing Cardiology Payment Models in Australia and the United States

Dimension	United States (Medicare physician fee schedule)	Australia (Medicare Benefits Schedule and private arrangements)
Primary pricing body	Centers for Medicare and Medicaid Services (CMS)	Department of Health and Aged Care, with MBS Review Taskforce input
Recent cardiology trend	Consecutive annual cuts driven by budget neutrality and code revaluation	Periodic item reviews, with selective reductions and new item introductions
Patient cost transparency	Variable; often opaque until a bill is generated	Schedule fees published; out-of-pocket gaps depend on the provider billing choice
Clinician recourse	Comment letters, advocacy campaigns, occasional legal challenges	Committee submissions, peak-body representation, professional society input
Independent scrutiny	GAO, OIG, and MedPAC reports	Senate committee inquiries, IHACPA work, Auditor-General reports

The snapshot above hides an important asymmetry. Australian patients who skip public hospital queues often pay a known gap defined by the difference between the MBS schedule fee and what the specialist charges, sometimes multiples of the schedule fee for complex interventional work. American patients face coinsurance, deductibles, and assignment rules, on top of the question of whether any cardiology practice still accepts new Medicare patients in their postcode. Both systems benefit from clearer explanation of how a fee was derived, but the US debate is currently more heated because cardiology is being singled out for serial reductions.

Patient Stories and the Road to Public Accountability

Numbers, on their own, rarely move the political needle in a democracy. Stories do. The campaign has worked to surface patient narratives of delayed angiograms, longer drives from rural regions equivalent to remote South Australia, and small cardiology practices that quietly stopped scheduling certain procedures because reimbursement no longer covered disposables. Each narrative is paired with a question: if the formula is correct and the cut is justified, why does access worsen in measurable ways?

That pairing of experience and evidence now shapes testimony before US congressional committees and submission dossiers for federal rule-making. Australian patient-advocacy groups, including the Heart Foundation, have built decades of similar storytelling muscle, mobilising around risk factors, rehab access, and rural service gaps. A useful cross-Pacific observation is that emotional testimony lands hardest when the audience can also see the underlying calculation that produced the disputed figure. Without numbers, the story reads as anecdote. With numbers, it reads as a pattern.

What Transparency Would Change, in Practice

Opening the formulas would not, by itself, stop fee schedule reductions. Fee schedules are adjusted for many reasons, including macroeconomic pressures, budget constraints, and new clinical evidence. What transparency does change is the basis on which those adjustments are argued, in committee rooms and in public hearings alike. It shifts the conversation from a defence of secrecy to a search for the most defensible figure available.

What the campaign has demanded from policymakers:

• Publishing the data sources behind each cardiology code valuation update, including survey samples used to estimate practice expenses.
• Mandating an annual public explanation whenever specialty-level payment changes exceed a defined threshold.
• Releasing impact analyses in machine-readable formats so independent academic centres can replicate them.
• Creating a standing patient advisory channel that reviews cardiology payment shifts before they are finalised.
• Preserving historical valuation methodology so long-running trends, not just year-over-year changes, can be tracked.

The success of any of these demands ultimately depends on whether patients and practices engage with them when consultation windows open.

A short checklist for patients and practices following the debate:

• Note the date a fee change is proposed and the date it takes effect, since lag time can hide the impact.
• Identify which cardiology services are affected and where the nearest alternative provider sits.
• Look for impact analyses that include specialty-level totals, not just headline percentage figures.
• Compare the change against the previous five years to see whether it sits inside a trend.
• Submit a comment during the public consultation window, even a brief one, since volume of responses is tracked.

Both sets of demands point to the same conviction: a payment system that cannot explain itself cannot be trusted to be fair. Open methodology is what lets an outside observer distinguish a defensible cut from a bureaucratic shortcut, and Australian readers who follow the work of bodies such as the Independent Hospital and Aged Care Pricing Authority will recognise the spirit, if not the exact mechanism. The campaign, the patient advocates behind it, and the clinicians joining the call are converging on a simple idea. Open the formulas, walk through the math, and let patients and physicians judge whether the result is reasonable.

If you are a clinician, patient, or administrator in Australia watching these debates unfold, your perspective matters to a conversation that is larger than any one country. Subscribe to the campaign's updates, share your story through the patient-access portal, and add your voice to the public comment record the next time a cardiology reimbursement proposal lands in the federal register.